Page results
-
UCLH Pain Management Centre is a nationally recognized centre of excellence for people with longstanding pain.
-
Stroke services at UCLH provide the best possible clinical care for all phases of the stroke pathway.
-
Information for relatives following bereavement and about the role of the Medical Examiner Service at UCLH.
-
This page provides information on giving babies vitamin K shortly after they are born.
-
Functional dyspepsia and gastroparesis often co-exist. There are good treatment pathways for managing the symptoms associated with these conditions.
-
The Upper GI service provides treatment for, amongst other conditions, oesophageal and gastric cancers as well as for benign conditions (acid reflux and motility disorders). There is close collaboration with the GI physiology and laser centre.
-
Our clinical neurophysiology department performs tests which record information from the brain or the nervous system. There are two main tests performed in our outpatient department, Electroencephalogram (EEG) and Nerve conduction studies (NCS).
-
This clinic provides a service within North Central London to children and young people up to 18 years of age with unusual, complicated or recurrent infections. A family infection clinic is also provided where family groups may be reviewed together by both adult and paediatric teams.
-
Critical care incorporates general adult intensive care, high-dependency, the Post-Anaesthetic Care Unit (PACU), critical care outreach and the Critical Care Follow-up Clinic.
-
CAR T-cell therapy is a cutting-edge treatment for certain blood cancers, offering new hope to patients whose illness hasn’t responded to standard treatments. University College London Hospitals (UCLH) is proud to be one of Europe’s leading centres for this advanced care.
File results
-
FOI/2022/0385 - Stillbirths and infant deaths
-
FOI/2022/0386 - Permanent/ International Recruitment for medical and non medical staff
-
FOI/2022/0392 - Replacement of patient trolleys
-
FOI/2022/0393 - COVID-19 patient treatment between 16/03/2020 - 16/06/2020
-
FOI/2022/0399 - Staff networks at the Trust
-
FOI/2022/0402 - Breast Cancer patients (any stage) treatments
-
FOI/2022/0405 - Treatments C1-esterase inhibitor & immunoglobulin treatments
-
FOI/2022/0408 - Date UCLH became smoke-free
-
FOI/2022/0412 - Mental health inpatient facilities
-
FOI/2022/0413 - Head and neck cancer and urothelial cancer patients treatment and clinical trials